Fostamatinib Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Fostamatinib is used to treat thrombocytopenia (less than normal number of platelets) in adults with chronic immune thrombocytopenia (ITP; an ongoing condition that may cause unusual bruising or bleeding due to an abnormally low number of platelets in the blood) who were not helped with another treatment.Fostamatinib Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Fostamatinib Nitroso Impurity 1 CAS NO:NA chemically represented as (6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)(nitroso)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate. Synchemia is the leading manufacturing and exporter of Fostamatinib Nitroso Impurity 1 . We supply Fostamatinib Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141763 |
| CAS No | 856068-98-9 |
| Mol.F. | C9H14N2O2 |
| Mol.Wt. | 182.2 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141764 |
| CAS No | NA |
| Mol.F. | C16H12Cl2N6O2S |
| Mol.Wt. | 423.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141765 |
| CAS No | NA |
| Mol.F. | C22H25ClN8O4S |
| Mol.Wt. | 533.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141766 |
| CAS No | NA |
| Mol.F. | C22H25ClN8O4S |
| Mol.Wt. | 533.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141767 |
| CAS No | NA |
| Mol.F. | C12H12N2O7 |
| Mol.Wt. | 296.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141768 |
| CAS No | NA |
| Mol.F. | C16H16FN5O6 |
| Mol.Wt. | 393.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141769 |
| CAS No | NA |
| Mol.F. | C16H17FN4O5 |
| Mol.Wt. | 364.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141770 |
| CAS No | NA |
| Mol.F. | C16H17FN4O5 |
| Mol.Wt. | 364.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141771 |
| CAS No | NA |
| Mol.F. | C15H15FN4O5 |
| Mol.Wt. | 350.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141772 |
| CAS No | NA |
| Mol.F. | C15H14F4N2O5 |
| Mol.Wt. | 378.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141773 |
| CAS No | NA |
| Mol.F. | C15H14FN3O5 |
| Mol.Wt. | 335.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141774 |
| CAS No | NA |
| Mol.F. | C20H22N8O8 |
| Mol.Wt. | 502.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141775 |
| CAS No | NA |
| Mol.F. | C20H24N8O7 |
| Mol.Wt. | 488.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141776 |
| CAS No | NA |
| Mol.F. | C20H21N9O8 |
| Mol.Wt. | 515.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141777 |
| CAS No | NA |
| Mol.F. | C20H22N8O7 |
| Mol.Wt. | 486.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141778 |
| CAS No | NA |
| Mol.F. | C20H22N8O7 |
| Mol.Wt. | 486.4 |
| INV STATUS | CUSTOM SYNTHESIS |